Nishino, K., Kunimasa, K., Kimura, M., Inoue, T., Tamiya, M., Kuhara, H., & Kumagai, T. (2020). Favorable response to pembrolizumab after durvalumab failure in a stage III sarcomatoid carcinoma of the lung: A case report. BMC Pharmacol Toxicol.

Nishino, Kazumi, Kei Kunimasa, Madoka Kimura, Takako Inoue, Motohiro Tamiya, Hanako Kuhara, and Toru Kumagai. "Favorable Response to Pembrolizumab After Durvalumab Failure in a Stage III Sarcomatoid Carcinoma of the Lung: A Case Report." BMC Pharmacol Toxicol 2020.

Nishino, Kazumi, et al. "Favorable Response to Pembrolizumab After Durvalumab Failure in a Stage III Sarcomatoid Carcinoma of the Lung: A Case Report." BMC Pharmacol Toxicol 2020.